Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nutraceutical Combination May Benefit Overweight Subjects - Nutraceuticals World

What are you searching for?

Sign in
Research

Nutraceutical Combination May Benefit Overweight Subjects

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Overweight subjects easily develop alterations of the glucose and lipid metabolism and are exposed to an increased cardiometabolic risk. This condition is potentially reversible through the improvement of dietary and behavioral habits. However, a well-assembled nutraceutical would be a useful tool to better improve the metabolic parameters associated with overweight and insulin resistance.

Researchers sought to evaluate the effect of a combined nutraceutical containing berberine, chlorogenic acid and tocotrienols. They performed a double-blind, crossover designed trial versus placebo in 40 overweight subjects with mixed hyperlipidaemia. Results were published in Nutrition Journal (March online). After the first 8 weeks of treatment (or placebo), patients were asked to observe a 2-week washout period, and they were then assigned to the alternative treatment for a further period of 8 weeks.

Clinical and laboratory data associated with hyperlipidemia and insulin resistance were obtained at baseline, at the end of the first treatment period, after the washout, and again after the second treatment period.

According to study results, both groups experienced a significant improvement of anthropometric and biochemical parameters versus baseline. However, total cholesterol, LDL cholesterol, triglycerides, non-HDL cholesterol, fasting insulin, HOMA-IR, GOT and Lipid Accumulation Product decreased more significantly in the nutraceutical group versus placebo.

Researchers concluded this combination seems to improve a large number of metabolic and liver parameters in the short-term in overweight subjects. Further studies are needed to confirm these observations in the middle- and long-term.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics